Deanna L. Russell
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Cancer Immunotherapy and Biomarkers, Pharmacological Receptor Mechanisms and Effects, Cancer, Stress, Anesthesia, and Immune Response, Epigenetics and DNA Methylation
Most-Cited Works
- → Predisposition Locus for Major Depression at Chromosome 12q22-12q23.2(2003)197 cited
- → Activation of Hormone-sensitive Lipase Requires Two Steps, Protein Phosphorylation and Binding to the PAT-1 Domain of Lipid Droplet Coat Proteins(2009)164 cited
- → TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition(2006)150 cited
- → A Major Predisposition Locus for Severe Obesity, at 4p15-p14(2002)139 cited
- → Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial(2024)108 cited
- → Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response(2020)97 cited
- → CGI-58/ABHD5 is phosphorylated on Ser239 by protein kinase A: control of subcellular localization(2014)75 cited
- → Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors(2022)69 cited
- → Linkage of body mass index to chromosome 20 in Utah pedigrees(2001)53 cited
- → STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1(2020)51 cited